These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10711075)

  • 1. Use of lispro insulin and quality of life in adolescents on intensive therapy.
    Grey M; Boland EA; Tamborlane WV
    Diabetes Educ; 1999; 25(6):934-41. PubMed ID: 10711075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on clinical status and quality of life of switching from regular insulin to insulin lispro among patients using insulin pumps.
    Campbell RK; Sclar DA; Robison LM; Stowers JK; Ferguson JC; Trippe BS; Kayne DM
    Diabetes Educ; 1998; 24(1):95-9. PubMed ID: 9526330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
    Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
    An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy.
    Kotsanos JG; Vignati L; Huster W; Andrejasich C; Boggs MB; Jacobson AM; Marrero D; Mathias SD; Patrick D; Zalani S; Anderson J
    Diabetes Care; 1997 Jun; 20(6):948-58. PubMed ID: 9167105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lispro analog and quality of life].
    Tubiana-Rufi N; Munz-Licha G
    Diabetes Metab; 1997 Sep; 23 Suppl 3():58-62. PubMed ID: 9410554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus.
    Recasens M; Aguilera E; Morínigo R; Casamitjana R; Nicoletti F; Gomis R; Conget I
    Diabetes Res Clin Pract; 2003 Jun; 60(3):153-9. PubMed ID: 12757987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of coping skills training as adjunct to intensive therapy in adolescents.
    Grey M; Boland EA; Davidson M; Yu C; Sullivan-Bolyai S; Tamborlane WV
    Diabetes Care; 1998 Jun; 21(6):902-8. PubMed ID: 9614605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A questionnaire survey on the use of quick-acting insulin analog in Japanese children and adolescents with type 1 diabetes.
    Urakami T; Kawamura T; Sugihara S; Miyamoto S; Amemiya S; Sasaki N; Matsuura N;
    Pediatr Int; 2004 Jun; 46(3):285-90. PubMed ID: 15151544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
    Durnwald CP; Landon MB
    J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On calculating treatment satisfaction.
    Bradley C
    Diabetes Care; 1999 Oct; 22(10):1760. PubMed ID: 10526762
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of type 1 diabetes with insulin lispro during Ramadan.
    Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
    Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
    Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.
    Skrha J; Smahelová A; Andĕl M; Vrtovec M; Subić J; Kreze A; Vozar J; Korecová M; de Verga V; Wyatt J; Metcalfe S; Ristić S
    Sb Lek; 2002; 103(1):15-21. PubMed ID: 12448933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of insulin glargine and nutritional model on metabolic control, quality of life and behavior in children and adolescents with type 1 diabetes mellitus.
    Goksen D; Darcan S; Buyukinan M; Köse T; Erermis S; Coker M
    Acta Diabetol; 2008 Mar; 45(1):47-52. PubMed ID: 17928940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
    Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog).
    Roper NA; Bilous RW
    Diabet Med; 1998 Dec; 15(12):1063-4. PubMed ID: 9868982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.